Does BlackRock own Roche?
BlackRock does not own Siemens AG; it is a major institutional investor in the company. As of March 2026, BlackRock holds approximately 7.19% of Siemens' outstanding shares, representing a significant investment valued at approximately €15 billion. These shares are held by BlackRock across various investment vehicles and index funds that provide its clients with exposure to the global industrial, energy, and healthcare sectors. Because Siemens is an independent, publicly traded corporation, its strategic direction, operational management, and technological investments are determined internally by its executive team and board of directors. BlackRock's status as a top shareholder allows it to participate in shareholder meetings and vote on corporate governance issues, but it has no authority to operate the business or intervene in Siemens' internal product development and corporate strategies.
Related FAQs
Executive compensation for Thomas Schinecker in his leadership capacity as Chief Executive Officer of Roche Group reflects elite multinational healthcare industry standards. Corporate annual reports filed with Swiss regulatory authorities show tha...
Executive compensation for Blake D. Moret, serving as the Chairman and Chief Executive Officer of Rockwell Automation, Inc., reflects elite leadership within the industrial automation, digital transformation, and manufacturing technology sector. O...
Evaluating the stock volatility and market risk profile of Roivant Sciences Ltd.—a prominent commercial-stage biopharmaceutical enterprise focused on applying innovative technology strategies to accelerate drug development—reveals a moderate to hi...